Evidence map›Paper›PMID 32793433›Full record

ArticleChemosensors (Basel, Switzerland)2019

A Peptide-Lectin Fusion Strategy for Developing a Glycan Probe for Use in Various Assay Formats.

Butaek Lim, LeNaiya Kydd, Justyn Jaworski

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemosensors (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Butaek LimDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX 76010, USA.
LeNaiya KyddDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX 76010, USA.
Justyn JaworskiDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX 76010, USA.
The University of Texas at Arlington · US

Funding

Interdisciplinary Training in Nanotechnology for Cardiovascular and Lung Diseases in North TexasT32HL134613 · NHLBI · UNIVERSITY OF TEXAS ARLINGTON · PI NGUYEN, KYTAI TRUONG · 2017 to 2021
$1.1M
Development of novel liposome-based assays for quantifying anti-glycan antibody levels in serumR15GM135892 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI JAWORSKI, JUSTYN · 2019 to 2019
$373k
NHLBI NIH HHS T32 HL134613NIGMS NIH HHS R15 GM135892
6 · The paper itself

Abstract

While nucleic acid and protein analysis approaches continue to see significant breakthroughs, analytical strategies for glycan determination have by comparison seen slower technological advances. Here we provide a strategy for glycan probe development using an engineered lectin fusion that can be incorporated into various common pathology lab assay formats including Western blot and agglutination assays. In this proof of concept, we use the natural lectin,

Indexed as

agglutination assaylectinoligomannosePseudomonas fluorescens agglutininWestern blot assay

Identifiers

PMID32793433
PMCPMC7423246
OpenAlexW2988587660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.